Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
deproteinized calf blood extract (Jiangshi Pharmaceutical)
- Development stage
- Unknown
- Lead developer
- Heilongjiang Jiangshi Pharmaceutical
- Administration
- Intravenous, Intramuscular
01
Overview
Ourui (deproteinized calf blood extract) is a biological extract derived from bovine blood, developed and manufactured by Heilongjiang Jiangshi Pharmaceutical. It is primarily used for the treatment of neurological and metabolic disorders, including cerebral insufficiency, stroke, and peripheral arterial disease. The extract contains a complex mixture of low-molecular-weight components such as amino acids, oligopeptides, and nucleosides. Its mechanism of action involves enhancing cellular oxygen uptake and glucose utilization, thereby improving energy metabolism in tissues under hypoxic or ischemic conditions. It is administered via injection and is approved in China for various indications related to tissue repair and metabolic support.
- Brand names
- Ourui欧瑞
- Other names
- 注射用小牛血去蛋白提取物Deproteinized Calf Blood Extract for Injection
02
Targets
SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)
Beyond the preview
Go deeper on deproteinized calf blood extract (Jiangshi Pharmaceutical).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on deproteinized calf blood extract (Jiangshi Pharmaceutical).